A polymorphism of the interleukin-1 receptor antagonist plays a prominent role within the interleukin-1 gene cluster in vulvar carcinogenesis
- 31 March 2004
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 92 (3) , 936-940
- https://doi.org/10.1016/j.ygyno.2003.11.039
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Clinical significance of interleukin-1 receptor antagonist in patients with cervical carcinomaPublished by Elsevier ,2014
- The balance between IL-1 and IL-1Ra in diseaseCytokine & Growth Factor Reviews, 2002
- Influence of Interleukin‐1 Receptor Antagonist Gene Polymorphism on DiseaseClinical Infectious Diseases, 2002
- Activation of transcription factor NF-κB by growth inhibitory cytokines in vulvar carcinoma cellsImmunology Letters, 2000
- Interleukin-1, Interleukin-1 Receptors and Interleukin-1 Receptor AntagonistInternational Reviews of Immunology, 1998
- Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphismClinical and Experimental Immunology, 1995
- A Physical Map of the Region Encompassing the Human Interleukin-1α, Interleukin-1β, and Interleukin-1 Receptor Antagonist GenesGenomics, 1994
- Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeatHuman Genetics, 1993
- Single base polymorphism at −511 in the human interleukin-1β gene (IL1β)Human Molecular Genetics, 1992
- A Taql polymorphism in the human interleukin‐1β (IL‐1β) gene correlates with IL‐1β secretion in vitroEuropean Journal of Clinical Investigation, 1992